Clinical trial
The Safety and Efficacy of the Percutaneous Left Ventricular Assist System for Intraoperative Circulatory Support During High-risk Percutaneous Coronary Intervention (PCI): a Prospective, Multi-center, Randomized Controlled Study
NCT06357026 is registered in ClinicalTrials.gov with Shanghai NewMed Medical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of the Percutaneous Left Ventricular Assist System for Intraoperative Circulatory Support During High-risk Percutaneous Coronary Intervention (PCI): a Prospective, Multi-center, Randomized Controlled Study
- Lead sponsor
- Shanghai NewMed Medical Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2024
- Completion date
- April 1, 2026
- Enrollment
- 344 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.